在一体化磁共振直线加速器上进行立体定向消融放疗治疗淋巴结和肝脏寡转移疾病的首个多中心经验。
First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac.
作者信息
Janssen Tomas M, Aitken Katharine, Alongi Filippo, Barry Aisling, Bernchou Uffe, Boeke Simon, Hall William A, Hosni Ali, Kroon Petra S, Nachbar Marcel, Saeed Hina, Jürgenliemk-Schulz Ina M, Schytte Tine, Verkooijen Helena M, Nowee Marlies E
机构信息
Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Radiotherapy, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK.
出版信息
Tech Innov Patient Support Radiat Oncol. 2022 May 10;22:50-54. doi: 10.1016/j.tipsro.2022.04.005. eCollection 2022 Jun.
The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.
使用磁共振（MR）引导治疗寡转移疾病是一个不断发展的领域。自2018年8月起，患者在一台1.5特斯拉的磁共振直线加速器（MRL）上接受治疗。我们展示了来自七个机构针对首批接受淋巴结和肝转移治疗患者的当前工作流程和实践标准。
Zotero 插件